Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radionuclide imaging in drug development.

Alan C Perkins1, Malcolm Frier

  • 1Department of Medical Physics, University Hospital Queens Medical Centre, Nottingham, UK. alan.perkins@nottingham.ac.uk

Current Pharmaceutical Design
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seracam: characterisation of a new small field of view hybrid gamma camera for nuclear medicine.

EJNMMI physics·2024
Same author

Feasibility Study of a New Magnetic Resonance Imaging Mini-capsule Device to Measure Whole Gut Transit Time in Paediatric Constipation.

Journal of pediatric gastroenterology and nutrition·2020
Same author

Gastric emptying: a dog's dinner.

Nuclear medicine communications·2020
Same author

Simultaneous Measurement of Gastric Emptying of a Soup Test Meal Using MRI and Gamma Scintigraphy.

Diagnostics (Basel, Switzerland)·2020
Same author

Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster.

Molecular metabolism·2020
Same author

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis.

Pharmaceutics·2019
Same journal

Fentanyl and its Analogs: A Medicinal Chemistry Perspective on Therapeutic Potential and Abuse Liability.

Current pharmaceutical design·2026
Same journal

Acne Vulgaris: Integrating Pathophysiology with Conventional, Herbal, and Nanocarrier-Based Therapeutic Strategies.

Current pharmaceutical design·2026
Same journal

Systems Pharmacology and Pharmaco-Transcriptomic Insights into Bauhinia variegata for Polycystic Ovary Syndrome Management.

Current pharmaceutical design·2026
Same journal

Curcumin and Cognitive Health: Insights from Randomized Controlled Trials.

Current pharmaceutical design·2026
Same journal

Inorganic Materials-integrated Porphyrin for Drug Delivery in Cancer Therapy: Promises, Challenges and Outlooks.

Current pharmaceutical design·2026
Same journal

Precision Nanotechnology in Oral Oncology: From Biomarker-Guided Targeting to AI-Driven Theranostics.

Current pharmaceutical design·2026
See all related articles

Nuclear imaging uses radioactive tracers to visualize drug delivery and uptake in the body. This technology aids in understanding drug behavior and developing targeted therapeutics for improved patient outcomes.

Area of Science:

  • Nuclear medicine
  • Radiopharmacy
  • Pharmacology

Background:

  • Radioactive tracers are crucial for understanding human physiology and pathology.
  • Nuclear imaging is a key metabolic imaging technique in drug development and clinical pharmacology.
  • Radiolabeling allows visualization of drug release, biodistribution, and uptake in vivo.

Purpose of the Study:

  • To highlight the application of nuclear imaging in drug development and clinical pharmacology.
  • To demonstrate the capability of imaging studies in locating specific biological targets and drug delivery sites.
  • To emphasize the role of nuclear molecular imaging in evaluating drug delivery systems and targeted therapeutics.

Main Methods:

  • Radiolabeling of drug molecules and carrier systems using gamma emitters (e.g., 99mTc) or positron emitters (e.g., 18F).

Related Experiment Videos

  • Utilizing imaging techniques like gamma cameras and positron emission tomography (PET).
  • Quantifying in vivo distribution and kinetics of radiolabeled pharmaceuticals.

    • Main Results:

    • Imaging studies can pinpoint receptor uptake in the brain, tablet disintegration in the GI tract, lung penetration of nebulized solutions, and eye drop residence time.
    • Positron emitters are suitable for direct labeling of drug molecules.
    • Quantification of in vivo distribution and kinetics allows correlation between pharmacological effects and delivery site.

    Conclusions:

    • Nuclear molecular imaging provides valuable data on drug delivery system characteristics like reliability and reproducibility.
    • This technology demonstrates proof of principle for novel targeted therapeutics.
    • Imaging data are increasingly utilized in regulatory submissions for product registration.